@prefix dcterms: . @prefix this: . @prefix sub: . @prefix np: . @prefix npx: . @prefix xsd: . @prefix orcid: . @prefix rdfs: . @prefix fip: . @prefix prov: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:LACDR-DDS-CTDS dcterms:isPartOf ; a fip:FAIR-Implementation-Community; rdfs:comment "In this research group, headed by prof. dr. Bob van de Water, cell signaling programs that underlie adverse drug reactions as well as cancer development and progression are unraveled."; rdfs:label "Cancer Therapeutics and Drug Safety, Division of Drug Discovery & Safety, LACDR, Leiden University"; rdfs:seeAlso ; fip:has-research-domain . } sub:provenance { sub:assertion dcterms:creator orcid:0000-0001-7525-9218 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCoKFb7LKlXyBB7BUvjFF9bDJNk0WxH3Xerr4H3v/VCiRVshEDl3BZVekbMMmdRe+TOPyc8AOLd9IAL2VfVVD/T0rmCHk7Pw7DQjI96mwyeXhE7f4g0WG5UT5Pxxm0Rzy7IrYnEaaVDs7dkZUt952M6qWlHfTwCQDcXJhZfLiXoMwIDAQAB"; npx:hasSignature "f/glNqNNjIOr7rP0fR/pKIoIAJZyoYkKvt4m2i07Dn/KqNGSM8D8/ltM28jtvLkSQGOOeE04eIlHs4kuRX0IQLx9Aa46y9XWs0P747Vs7TXOr+r/yGby1FvH3A5SqZHjyb2DkCcfDrp9vL8o8L1NV/9c64PnxYoJdKWHTfu+qQk="; npx:hasSignatureTarget this: . this: dcterms:created "2023-01-19T14:26:48Z"^^xsd:dateTime; dcterms:creator ; dcterms:license ; npx:introduces sub:LACDR-DDS-CTDS; prov:wasDerivedFrom . }